Back to Search
RUSSELL BROADDUS, M.D., PH.D.
M.D., PH.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1891881967IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
2019-02095(NC)
CMS Specialties
PrimaryPATHOLOGY
Education
UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Class of 1994
Research & Publications (20)
Women with HNPCC: a target population for the chemoprevention of gynecologic cancers.
PMID 16720294·Front Biosci·2006
6-review
Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.
PMID 16323174·Cancer·2006
4-observational
The chemopreventive agents 4-HPR and DFMO inhibit growth and induce apoptosis in uterine leiomyomas.
PMID 15042000·Am J Obstet Gynecol·2004
8-other
Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome.
PMID 15143336·Mod Pathol·2004
5-case
Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence.
PMID 12946222·Arch Pathol Lab Med·2003
8-other
Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma.
PMID 19241422·Cancer·2009
3-trial
EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
PMID 19396818·Cancer·2009
8-other
Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis.
PMID 19436036·J Natl Cancer Inst·2009
7-preclinical
Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.
PMID 19622772·Cancer Res·2009
4-observational
Clinicopathological features in endometrial carcinoma associated with Lynch syndrome in China.
PMID 19509565·Int J Gynecol Cancer·2009
8-other
Mig-6 modulates uterine steroid hormone responsiveness and exhibits altered expression in endometrial disease.
PMID 19439667·Proc Natl Acad Sci U S A·2009
7-preclinical
Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy.
PMID 19216791·Mol Cancer·2009
6-review
Enhanced estrogen-induced proliferation in obese rat endometrium.
PMID 19185100·Am J Obstet Gynecol·2009
4-observational
15-LOX-1 transcription suppression through the NuRD complex in colon cancer cells.
PMID 19198625·Oncogene·2009
8-other
S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling.
PMID 19506550·Lab Invest·2009
8-other
Endometrial cancer and Lynch syndrome: clinical and pathologic considerations.
PMID 19078925·Cancer Control·2009
6-review
beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus.
PMID 18806829·Oncogene·2009
7-preclinical
Spermatogenesis associated retrogenes are expressed in the human ovary and ovarian cancers.
PMID 19333399·PLoS One·2009
8-other
Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome.
PMID 19001318·J Clin Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 101 MANNING DR
CHAPEL HILL, NC 27514 - Phone
- (919) 966-4676
Quick Facts
- NPI
- 1891881967
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile